Erymax 250mg Pill - orange clear capsule/oblong, 22mm
Pill with imprint Erymax 250mg is Orange / Clear, Capsule/Oblong and has been identified as Erythromycin Delayed-Release 250 mg. It is supplied by Midlothian Laboratories.
Erythromycin is used in the treatment of Bronchitis; Bacterial Endocarditis Prevention; Bowel Preparation; Bartonellosis; Bullous Pemphigoid and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Erymax 250mg
Erythromycin Delayed-Release
- Imprint
- Erymax 250mg
- Strength
- 250 mg
- Color
- Orange / Clear
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Macrolides
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Midlothian Laboratories
- National Drug Code (NDC)
- 68308-0250
- Inactive Ingredients
-
FD&C Yellow No. 6,
titanium dioxide
Note: Inactive ingredients may vary.
More about erythromycin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (67)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: macrolides
- Breastfeeding
- En español
Patient resources
Other brands
Erythrocin, Ery-Tab, E.E.S. Granules, Eryc, ... +4 more
Professional resources
- Erythromycin monograph
- Erythromycin Ethylsuccinate (AHFS Monograph)
- Erythromycin Lactobionate (AHFS Monograph)
- Erythromycin Stearate (AHFS Monograph)
- Erythromycins General Statement (AHFS Monograph)
Other brands
Erythrocin, Ery-Tab, E.E.S. Granules, EryPed, PCE Dispertab
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.